Literature DB >> 16205156

Chondromyxoid fibroma: a rarely encountered and puzzling tumor.

Ana Lersundi1, Henry J Mankin, Anastasios Mourikis, Francis J Hornicek.   

Abstract

Chondromyxoid fibroma is an uncommon bone neoplasm, accounting in our series for less than 1% of all connective tissue tumors. The tumor is more common in males, and located mostly in the metaphyseal areas of the lower extremity. The tumor is benign and there have been no reports of metastases. The method of treatment that has been used since the initial identification of the tumor has been curettage, which has a 20-25% recurrence rate. In our 30 patients, the average length of followup was 11 years (range, 1-29 years. Most of the tumors were in the pelvis, proximal tibia, distal femur, and foot. Tumors that were treated with curettage alone did less well than those that were packed with allograft bone or polymethylmethacrylate. Tumors treated by excision did not recur. The most difficult problem with chondromyxoid fibroma is pathologic identity because it often is confused with more aggressive tumors that may metastasize.

Entities:  

Mesh:

Year:  2005        PMID: 16205156     DOI: 10.1097/01.blo.0000174685.62379.6a

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  13 in total

1.  A case report on partial scapulectomy with glenoid preservation for Chondromyxoid fibroma of scapula.

Authors:  Naba Pallab Chetia; Aritra Bidyananda; Munin Borgohain
Journal:  J Clin Orthop Trauma       Date:  2017-12-28

2.  Intracortical chondromyxoid fibroma of the tibia.

Authors:  Óscar Fernández-Hernández; Luis Ramos-Pascua; Francisco Izquierdo-García
Journal:  Musculoskelet Surg       Date:  2011-08-04

3.  An intracortical chondromyxoid fibroma in the diaphysis of the metatarsal.

Authors:  Ji Sung Han; Euddeum Shim; Baek Hyun Kim; Jung-Woo Choi
Journal:  Skeletal Radiol       Date:  2017-08-15       Impact factor: 2.199

4.  Aggressive tibial lesion in a 70-year-old man.

Authors:  Jacob M Kirsch; Andrew E Rosenberg; Brian J O'Hara; John A Abraham
Journal:  Clin Orthop Relat Res       Date:  2014-05-28       Impact factor: 4.176

5.  Surface chondromyxoid fibroma of the distal ulna: unusual tumor, site, and age.

Authors:  Ibrahim Fikry Abdelwahab; Michael J Klein
Journal:  Skeletal Radiol       Date:  2013-09-21       Impact factor: 2.199

Review 6.  The imaging of cartilaginous bone tumours. I. Benign lesions.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-17       Impact factor: 2.199

7.  Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?

Authors:  Germán L Farfalli; Jose I Albergo; Nicolas S Piuzzi; Miguel A Ayerza; D Luis Muscolo; Lucas E Ritacco; Luis A Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

8.  Chondromyxoid fibroma of the skull base invading the occipitocervical junction: report of a unique case and discussion.

Authors:  Matthew Crocker; Robert Corns; Istvan Bodi; Antoine Zrinzo; Michael Gleeson; Nick Thomas
Journal:  Skull Base       Date:  2010-03

9.  An abnormal bone lesion of the scapula in a collegiate basketball player: a case report.

Authors:  Matthew S O'Brien; Allison Donnell; Jason Miller; Val Gene Iven; Mark Pascale
Journal:  J Athl Train       Date:  2013-04-05       Impact factor: 2.860

10.  Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.

Authors:  André Luis Giacometti Conceição; Erica Babeto; Natalia Maria Candido; Fernanda Craveiro Franco; Débora Aparecida Pires de Campos Zuccari; Jane Lopes Bonilha; José Antônio Cordeiro; Marilia Freitas Calmon; Paula Rahal
Journal:  J Cancer       Date:  2015-05-23       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.